We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

28 hedge funds and large institutions have $5.67M invested in Marker Therapeutics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0.02% more ownership

Funds ownership: 22.52% → 22.54% (+0.02%)

0% more funds holding

Funds holding: 28 → 28 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

48% less capital invested

Capital invested by funds: $10.9M → $5.67M (-$5.24M)

Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
I
INVST
Indiana
+$79.1K
2
UBS Group
UBS Group
Switzerland
+$75.6K
3
Citadel Advisors
Citadel Advisors
Florida
+$51.5K
4
BlackRock
BlackRock
New York
+$31.6K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$19K

Top Sellers

Rank Fund Capital Flow
1
WS
Wedbush Securities
California
-$377K
2
IAIM
International Assets Investment Management
Florida
-$10.9K
3
Northern Trust
Northern Trust
Illinois
-$3.67K
4
TRCT
Tower Research Capital (TRC)
New York
-$1.42K
5
RAM
Riggs Asset Management
Pennsylvania
-$791
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$3.02M – – –
ACM
2
Aisling Capital Management
New York
$886K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$686K +$19K +4,800 +2%
AAM
4
AR Asset Management
California
$208K +$11.9K +3,000 +4%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$202K +$13.1K +3,319 +5%
Renaissance Technologies
6
Renaissance Technologies
New York
$112K +$3.56K +900 +2%
Northern Trust
7
Northern Trust
Illinois
$91.5K -$3.67K -928 -3%
State Street
8
State Street
Massachusetts
$59.1K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$57.2K – – –
I
10
INVST
Indiana
$56.4K +$79.1K +20,000 New
UBS Group
11
UBS Group
Switzerland
$53.9K +$75.6K +19,104 New
BlackRock
12
BlackRock
New York
$53.6K +$31.6K +7,980 +72%
Creative Planning
13
Creative Planning
Kansas
$48.8K – – –
MAA
14
Matrix Asset Advisors
New York
$42.3K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$36.8K +$51.5K +13,032 New
Osaic Holdings
16
Osaic Holdings
Arizona
$20K – – –
Morgan Stanley
17
Morgan Stanley
New York
$9.61K – – –
Bank of America
18
Bank of America
North Carolina
$7.38K +$4 +1 +0%
ACM
19
ADAR1 Capital Management
Texas
$6.86K +$9.62K +2,432 New
TRCT
20
Tower Research Capital (TRC)
New York
$4.25K -$1.42K -359 -19%
RAM
21
Riggs Asset Management
Pennsylvania
$3.38K -$791 -200 -14%
US Bancorp
22
US Bancorp
Minnesota
$2.37K – – –
Wells Fargo
23
Wells Fargo
California
$654 – – –
Group One Trading
24
Group One Trading
Illinois
$502 – – –
HNB
25
Hilltop National Bank
Wyoming
$206 – – –
1
2

MRKR Hedge Fund Activity: Q3 2024 in Review

28 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q3 2024, worth a combined $5.67M — down 48% from $10.9M a quarter earlier.

Fund positioning in MRKR was balanced in Q3 2024: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was INVST, opening a new position worth an estimated $79.1K. The largest seller was Wedbush Securities, exiting entirely with an estimated $377K sold.

  • 28 institutional investors held Marker Therapeutics (MRKR) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $5.67M of Marker Therapeutics stock for Q3 2024, down 48% quarter-over-quarter.
  • 4 funds opened new Marker Therapeutics positions in Q3 2024 and 4 closed out, a net change of 0 holders.
  • The largest Marker Therapeutics buyer in Q3 2024 was INVST, an estimated $79.1K added.
  • The largest Marker Therapeutics seller in Q3 2024 was Wedbush Securities, an estimated $377K sold.

Based on aggregated 13F filings for Q3 2024.